Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Histopathology|July 27, 2010
Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinomaRyotaro Sonoda, Yoshio Naomoto, Yasuhiro Shirakawa, et al.
Langenbeck'S Archives of Surgery|January 18, 2006
Colonic interposition and supercharge for esophageal reconstructionYasuhiro Shirakawa, Yoshio Naomoto, Kazuhiro Noma, et al.
British Journal of Cancer|March 30, 2024
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunityMasaaki Akai, Kazuhiro Noma, Takuya Kato, et al.
Surgical Endoscopy|May 29, 2015
Surgeons have knowledge gaps in the safe use of energy devices: a multicenter cross-sectional studyYusuke Watanabe, Yo Kurashima, Amin Madani, et al.
Oncotarget|December 13, 2017
Iron depletion is a novel therapeutic strategy to target cancer stem cellsTakayuki Ninomiya, Toshiaki Ohara, Kazuhiro Noma, et al.
Annals of Gastroenterological Surgery|January 31, 2019
Multicenter retrospective study to evaluate the efficacy and safety of the double-flap technique as antireflux esophagogastrostomy after proximal gastrectomy (rD-FLAP Study)Shinji Kuroda, Yasuhiro Choda, Shinya Otsuka, et al.
Oncology Reports|January 17, 2009
Establishment of a lymph node metastasis model from subcutaneous tumors of gastrointestinal stromal tumor model cellsKazufumi Sakurama, Yoshio Naomoto, Toshiaki Ohara, et al.
Molecular Cancer Therapeutics|April 19, 2024
Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein AntibodyTeruki Kobayashi, Kazuhiro Noma, Seitaro Nishimura, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2023
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibodyNoriyuki Nishiwaki, Kazuhiro Noma, Toshiaki Ohara, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2023
PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancerKento Kawasaki, Kazuhiro Noma, Takuya Kato, et al.
Pageof 15